Literature DB >> 8317310

Antioxidant and anti-inflammatory activities of selenomethylene blue.

S Leyck1, H Oelschläger, M J Parnham.   

Abstract

The selenium derivative of methylene blue, has been compared with the parent compound. Unlike some organic selenium compounds neither of the compounds affected macrophage chemiluminescence nor did they catalyse the glutathione-dependent breakdown of hydroperoxides in vitro. However, both inhibited iron-induced hepatic lipid peroxidation, in vitro and ex vivo, the selenium derivative being 3-fold more active in this respect. Both compounds inhibited inflammatory paw oedema in the rat, selenomethylene blue being the more active. Selenomethylene blue, thus, does not exhibit a different anti-oxidant/anti-inflammatory profile from that of the parent sulphur compound, but exhibits increased inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317310     DOI: 10.1007/bf01991165

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  4 in total

1.  The radioprotective effect against gamma-irradiation of methylene blue in the rat with reference to serum enzymes and pancreatic protein fractions examined by isoelectric focusing.

Authors:  S O Chung; S Y Nam
Journal:  J Radiat Res       Date:  1975-12       Impact factor: 2.724

2.  Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones.

Authors:  J H Doroshow
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 3.  Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions.

Authors:  M J Parnham; E Graf
Journal:  Biochem Pharmacol       Date:  1987-10-01       Impact factor: 5.858

4.  Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells.

Authors:  W Martin; K M Drazan; A C Newby
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.